CurveBeam AI (ASX:CVB) Debt-to-Equity : 0.31 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Debt-to-Equity?

CurveBeam AI's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$1.02 Mil. CurveBeam AI's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$13.51 Mil. CurveBeam AI's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$46.93 Mil. CurveBeam AI's debt to equity for the quarter that ended in Dec. 2023 was 0.31.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for CurveBeam AI's Debt-to-Equity or its related term are showing as below:

ASX:CVB' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.31 Med: 0 Max: 0.31
Current: 0.31

During the past 3 years, the highest Debt-to-Equity Ratio of CurveBeam AI was 0.31. The lowest was -0.31. And the median was 0.00.

ASX:CVB's Debt-to-Equity is ranked worse than
57.29% of 700 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs ASX:CVB: 0.31

CurveBeam AI Debt-to-Equity Historical Data

The historical data trend for CurveBeam AI's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Debt-to-Equity Chart

CurveBeam AI Annual Data

Trend

Jun21

Jun22

Jun23

Debt-to-Equity

N/A

-0.31

CurveBeam AI Semi-Annual Data
	Jun21	Dec21	Jun22	Jun23	Dec23
Debt-to-Equity	N/A	N/A	N/A	-0.31	0.31

Competitive Comparison of CurveBeam AI's Debt-to-Equity

For the Medical Devices subindustry, CurveBeam AI's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CurveBeam AI's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where CurveBeam AI's Debt-to-Equity falls into.

CurveBeam AI Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

CurveBeam AI's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.354	+	13.491)	/	-48.1
	=	-0.31

CurveBeam AI's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.016	+	13.511)	/	46.926
	=	0.31

CurveBeam AI (ASX:CVB) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

CurveBeam AI Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CurveBeam AI (ASX:CVB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.curvebeamai.com

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines